Determination of Pilsicainide in Human Plasma and Urine by LC-MS /MS
SUO Wei,LI Jing,LIN Yang,WEI Yong-xiang,YANG Ke-xu,QIU Qi,WU Wei,ZHAO Gui-ping,DU Hai-yan,ZHOU Zi-jie,ZHANG Ying-chao
DOI: https://doi.org/10.11669/cpj.2013.18.017
2013-01-01
Abstract:OBJECTIVE To develop a sensitive and specific LC-MS /MS method for the determination of pilsicainide in human plasma and urine. METHODS The samples were processed by LLE( liquid-liquid extraction),acetonitrile-ammonium acetate( 0. 1‰ formic acid)-water was used as the mobile phase with isocratic elution( 25∶ 37. 5∶ 37. 5 in plasma,35 ∶ 6 ∶ 59 in urine),and separation was carried out on Welch Material Ultimate AQ-C18column( 2. 1 00 × 100 mm,3. 5 μm),setting the flow rate as 0. 35 mL·min-1,the column temperature at 25 ℃. The injection volume was 5 μL. ESI under positive ion mode and multiple reaction monitoring scan( MRM) were used for quantitative analysis with m / z 273. 4→110. 2 for pilsicainide and m/z 287. 4 →110. 2 for internal standard,methyl-pilsicainide. RESULTS The linear ranges of the calibration curves for pilsicainide were 1-1 200 μg·L-1for plasma and 1-150 mg·L-1for urine. The limitation of detection were 1 μg·L-1for plasma and 1 mg · L-1for urine. The correlation coefficient was between 0. 996 2 and 0. 999 1. The extraction recoveries,matrix effects,and intra-/ inter-assay precisions all met the requirements of pharmacokinetic studies. This approach was applied to determine pilsicainide concentrations in human plasma and urine in a clinical pharmacokinetic research. CONCLUSION This approach possesses convenience,accuracy,high sensitivity and good reproducibility,which can meet the requirements of pharmacokinetic studies.